Targeted delivery of immuno-RNase may improve cancer therapy

Abstract Background Immunotoxins are typical therapeutic drugs that can target cancer cells. They exploit the affinity of specific monoclonal antibodies or ligands to cancer cells to deliver a conjugated protein toxin to target sites, thus, attacking the cancer cells. Methods The immuno-RNase, Onc-V...

Full description

Bibliographic Details
Main Authors: Miaonan Sun, Liankun Sun, Dejun Sun, Chunmei Zhang, Mei Li
Format: Article
Language:English
Published: BMC 2018-04-01
Series:Cancer Cell International
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12935-018-0546-7